Celnor is a newly established platform for testing, inspection, certification and compliance (“TICC”) businesses. Inflexion invested in Celnor in 2023 from Enterprise Fund V.

  • Sector

    Business services

  • Headquarters

    Reading, UK

  • Fund


  • Investment date

    October 2023

  • Status


The company

Celnor was launched to consolidate a highly fragmented TICC market across two areas. Life Sciences will provide testing and scientific services to customers active in the Biochemicals, Industrials and Pharmaceuticals industries.  Environmental and Industrial Services will focus on testing, inspection and certification of assets, people and processes, such as testing for workplace safety.

The Inflexion difference

Inflexion has built up industry-leading expertise in consolidating the TICC market through a number of successful investments in the sector, including Phenna Group, Alcumus, BES Group and Cawood Scientific. This experience will allow Inflexion to build the business with an ambitious acquisition strategy.

Press releases